MAGINI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 2.009
EU - Europa 1.601
AS - Asia 589
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 3
Totale 4.207
Nazione #
US - Stati Uniti d'America 2.008
IE - Irlanda 391
UA - Ucraina 342
IT - Italia 321
HK - Hong Kong 184
SG - Singapore 127
SE - Svezia 121
CN - Cina 103
FI - Finlandia 94
DE - Germania 83
RU - Federazione Russa 75
VN - Vietnam 71
GB - Regno Unito 52
FR - Francia 46
TR - Turchia 34
KR - Corea 21
BE - Belgio 15
NL - Olanda 14
IR - Iran 13
UZ - Uzbekistan 12
CH - Svizzera 11
IN - India 10
RO - Romania 8
AT - Austria 7
MY - Malesia 7
PL - Polonia 5
CZ - Repubblica Ceca 4
ES - Italia 4
EU - Europa 3
GR - Grecia 3
LB - Libano 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EG - Egitto 2
IQ - Iraq 2
NO - Norvegia 2
BG - Bulgaria 1
CA - Canada 1
HR - Croazia 1
MA - Marocco 1
MD - Moldavia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 4.207
Città #
Chandler 469
Dublin 391
Jacksonville 187
San Mateo 184
Hong Kong 182
Perugia 141
Boardman 137
Ann Arbor 104
Medford 89
Princeton 88
Singapore 82
Dong Ket 69
Wilmington 69
Altamura 56
Andover 47
Beijing 46
Ashburn 39
Lawrence 38
Des Moines 36
Izmir 34
Saint Petersburg 25
Seoul 21
Woodbridge 18
Norwalk 16
Brussels 14
Helsinki 11
Rome 10
San Paolo di Civitate 10
Shanghai 10
Isfahan 9
Dronten 8
Falls Church 8
Florence 8
Los Angeles 8
Washington 8
Edinburgh 7
Kuala Lumpur 7
Redwood City 7
Auburn Hills 6
Houston 6
Milan 6
Munich 6
New York 6
Redmond 6
San Diego 6
Seattle 6
Chicago 4
Den Haag 4
Tappahannock 4
Timisoara 4
Calarasi 3
Cattolica 3
Dallas 3
Detroit 3
Little Rock 3
Rende 3
Rājsamand 3
Santiago De Compostela 3
Scandicci 3
Taranto 3
Aci Sant'Antonio 2
Atlanta 2
Birmingham 2
Brno 2
Cambridge 2
Cormeilles-en-Parisis 2
Frankfurt Am Main 2
Hanoi 2
Jesi 2
Lequile 2
Macerata 2
Mohali 2
Moscow 2
Nanjing 2
Oslo 2
Padova 2
Pune 2
Reggio Emilia 2
Shenyang 2
Tehran 2
Terni 2
Valenzano 2
Albano Laziale 1
Amsterdam 1
Bari 1
Bologna 1
Cairo 1
Chisinau 1
Clearwater 1
Esslingen am Neckar 1
Falkenstein 1
Groningen 1
Hangzhou 1
Islington 1
Kaohsiung 1
Kiev 1
Lappeenranta 1
Lausanne 1
Ludwigshafen 1
Madrid 1
Totale 2.849
Nome #
FORMULAZIONE E CARATTERIZZAZIONE DI NUOVI TIPI DI NANOPARTICELLE PER STRATEGIE DI “DRUG DELIVERY” A LIVELLO CEREBRALE 95
Identification and characterization of mature beta-hexosaminidases associated with human placenta lysosomal membrane 91
System biology of stress response addressed by FTIR analysis of whole yeast cells 90
Alternative splicing mechanisms orchestrating post-transcriptional gene expression: intron retention and the intron-rich genome of apicomplexan parasites 88
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenesis Type II Fibroblasts 79
Enhancement of lysosomal glycohydrolase activity in human primary B lymphocytes during spontaneous apoptosis 74
Carbon dioxide capture by immobilized carbonic anhydrase 73
beta-hexosaminidase over-expression affects glycosphingolipid metabolism in mammalian cells-52° Congresso SIB 70
Recruitment of beta-hexosaminidase activity on plasma membrane and human T-cell activation-52° Congresso SIB 70
RAPAMYCIN LOADED SOLID LIPID NANOPARTICLES: FORMULATION, CHARACTERIZATION AND INHIBITION OF mTORC1 ACTIVITY IN SH-SY5Y NEUROBLASTOMA CELLS. 69
Methods to Discriminate the Distribution of Acidic Glycohydrolases Between the Endosomal–Lysosomal Systems and the Plasma MembraneEndosome Signaling Part A 69
Oncogenic H-Ras Up-Regulates Acid β-Hexosaminidase by a Mechanism Dependent on the Autophagy Regulator TFEB 68
Assessment of safety and efficiency of nitrogen organic fertilizers from animal-based Protein Hydrolysates - a laboratory multidisciplinary approach 66
Evaluation of a LC-MS method for everolimus preclinical determination in brain by using [13C2D4]RAD001 internal standard 66
Plasma membrane associated beta-hexosaminidase activity increases during human T-cells activation 63
Jurkat T-cell stimulation up-regulates the expression of lysosomal β-hexosaminidase and β-galactosidase and triggers their recruitment to lipid microdomains 63
Lipid-Based Nanocarriers for CNS-Targeted Drug Delivery 62
Glycohydrolases β-hexosaminidase and β-galactosidase are associated with lipid microdomains of Jurkat T-lymphocytes 62
Acidic glycohydrolases localization and regulation: pathological implication 62
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 62
NANOPARTICLE-DRIVEN DRUG DELIVERY TO THE CNS: COMPARISON OF PLGA AND LIPID-BASED NAOPARTICLES IN MOUSE MODEL OF NEURODEGENERATIVE DISEASES 61
TFEB activation restores migration ability to Tsc1-deficient adult neural stem/progenitor cells 61
2D-Electrophoretic analysis for Alzheimer's Disease early marker identification in peripheral cells 59
Extending lifespan through autophagy stimulation: a future perspective 58
Human plasma membrane associated B-hexosaminidase A Hydrolizes GM2 ganglioside 57
PROTEIN EXPRESSION PROFILE OF PLASMEPSIN IV KNOCK DOWN PLASMODIUM BERGHEI PARASITE AND IMMUNOREACTIVE IDENTIFICATION 57
Plasma membrane β-galactosidase and β-hexosaminidase are associated to lipid raft of Jurkat T-cell upon raft clustering. 56
Abnormal cortical lysosomal β-hexosaminidase and β-galactosidase activity at post-synaptic sites during Alzheimer's disease progression 56
Cells over-expressing Ras show modulation of lysosomal enzymes activity 55
β-Hexosaminidase over-expression affects lysosomal glycohydrolases expression and glycosphingolipid metabolism in mammalian cells 55
Proteome Alterations in Equine Osteochondrotic Chondrocytes 55
Metagenomic and Metaproteomic Characterization of Enrichment Cultures on Polycyclic Aromatic Hydrocarbons 54
Roles of the Amino Terminal Region and Repeat Region of the Plasmodium berghei Circumsporozoite Protein in Parasite Infectivity 54
TFEB activation promotes the recruitment of lysosomal glycohydrolases β-hexosaminidase and β-galactosidase to the plasma membrane 54
Identification and characterization of a fully processed beta-hexosaminidase isoform associated to lysosomal membrane-52° Congresso SIB 53
Human lysosomal α-D-mannosidase regulation in promyelocytic leukaemia cells. 52
Characterization of human lysosomal α-D-mannosidase in leukaemic and non leukaemic cells 52
FIBROBLASTS FROM PS1 MUTATED PRE-SYMPTOMATIC SUBJECTS AND ALZHEIMER’S DISEASE PATIENTS SHARE A UNIQUE PROTEIN LEVELS PROFILE. 51
Effect of pH on potassium metabisulphite biocidic activity against yeast and human cell cultures 51
Functional metaproteome analysis of microbial populations in enrichment cultures on polycyclic aromatic hydrocarbons 50
Potassium metabisulfite treatement alters human fibroblast protein expression pattern. 50
Evidence of tRNA cleavage in apicomplexan parasites: Half-tRNAs as new potential regulatory molecules of Toxoplasma gondii and Plasmodium berghei 49
Rapamycin Loaded Solid Lipid Nanoparticles as a New Tool to Deliver mTOR Inhibitors: Formulation and in Vitro Characterization 49
Curcumin Analogue C1 Promotes Hex and Gal Recruitment to the Plasma Membrane via mTORC1-Independent TFEB Activation 49
Carbon dioxide capture at gas emission site by carbonic anhidrase 48
TFEB overexpression promotes the translocation of lysosomal glycohydrolases beta-hexosaminidase and beta-galactosidase to cell surface lipid microdomains 48
Identification of plasma membrane associated mature B-hexosaminidase A, active towards GM2 ganglioside, in human fibroblasts 47
New perspectives for the diagnosis of Alzheimer's disease. 47
Effect of potassium metabisulfite in human fibroblast. 47
Therapeutic Approaches for Lysosomal Storage Diseases: A Patent Update 47
Glycosphingolipid metabolism is affected by beta-hexosaminidase over-expression in mammalian cells 46
Transcriptional regulation of glycosphingolipids degrating enzymes 46
Expression of the glycolytic enzymes enolase and lactate dehydrogenase during the early phase of Toxoplasma differentiation is regulated by an intron retention mechanism 46
Drug delivery strategies for mTOR inhibitors therapy in neurodegenerative and neuro-oncologic disease. 46
null 45
Enzymes for capturing greenhouse gases: use of immobilized carbonic anhydrase to develop a bioreactor subtracting carbon dioxide from mixed gas streams 45
PHYSICOCHEMICAL CHARACTERIZATION OF RAPAMYCIN-LOADED SOLID LIPID NANOPARTICLES FOR BRAIN TARGETING 45
Cathepsin L increased level upon Ras mutants expression: the role of p38 and p44/42 MAPK signaling pathways 44
β-Hexosaminidase α-subunit overexpression affects lipid microdomain glycohydrolases content 44
PHYSICOCHEMICAL CHARACTERIZATION OF RAPAMYCIN-LOADED SOLID LIPID NANOPARTICLES FOR BRAIN TARGETING 43
Changes in Lipid Composition During Manganese-Induced Apoptosis in PC12 Cells 42
Derivatized nanoparticle for CSN-target drug delivery 40
Proteome characterization of a microbial community response to polycyclic aromatic hydrocarbons exposure. 40
Cellular redox imbalance and S-glutathionylation of target proteins promote senescence induced by oncogenic H-Ras. 39
Modified PLGA-NPS able to cross the blood-brain barrier for the delivery of lysosomal enzymes in llysosomal storage disease 39
Cellular Redox Imbalance and Changes of Protein S-glutathionylation Patterns Are Associated with Senescence Induced by Oncogenic H-Ras 39
mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model 39
Ras mutants specifically regulates lysosomal glycohydrolases activity in different cell models. 38
Rapamycin-loaded solid lipid nanoparticles for brain targeting 38
Recruitment of plasma membrane β-galactosidase and β-hexosaminidase in lipid rafts upon T-cell activation 37
Solid lipid nanoparticle as a tool to deliver mTOR inhibitors 36
Regulation of lysosomal genes by miRNA 35
Ras differentially regulates lysosomal enzymes expression 35
Rapamycin-loaded solid lipid nanoparticles: morphology and impact of the drug loading on the phase transition between lipid polymorphs 34
Plasma membrane associated beta-hexosaminidase: biological significance and regulation 33
Occurrence of an anomalous endocytic compartment in fibroblasts from Sandhoff disease patients 32
Identification of lysosomal membrane associated, fully processed beta-hexosaminidase enzyme 31
Plasma membrane associated beta-hexosaminidase activity during human T-cells activation 31
Intrathecal administration of mTOR inhibitors for the therapy of neurodegenerative, neuroinflammatory and neurooncologic diseases 31
Evidence for the presence of human B-hexosaminidase B as lysosomal membrane associated protein 30
Everolimus treatment reduces proliferation of TSC1-deficient adult neural stem/progenitor cells and restores their migration capability. 30
RECENT DEVELOPMENTS IN THERAPEUTIC APPROACHES FOR LYSOSOMAL STORAGE DISORDERS 29
Signaling Pathways in Exosomes Biogenesis, Secretion and Fate 29
Ras differentially regulates lysosomal enzymes expression 29
Chaperone Therapy for GM2 Gangliosidosis: Effects of Pyrimethamine on β-Hexosaminidase Activity in Sandhoff Fibroblasts 28
hLGDB: a database of human lysosomal genes and their regulation 27
Hypermethylation contributes to down-regulation of lysosomal β-hexosaminidase α subunit in prostate cancer cells. 24
KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced S-Glutathionylation of Distinct Structural and Regulatory Proteins. 24
A Stable Micellar Formulation of RAD001 for Intracerebroventricular Delivery and the Treatment of Alzheimer’s Disease and Other Neurological Disorders 17
null 14
Proteomic analysis of murine Tsc1-deficient neural stem progenitor cells 11
Proteome characterization of a microbial community response to polycyclic aromatic hydrocarbons exposure 9
Totale 4.464
Categoria #
all - tutte 19.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.742


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020355 0 0 54 13 57 9 65 16 58 46 21 16
2020/2021684 9 56 16 57 226 26 53 4 84 16 60 77
2021/2022676 11 119 17 23 19 4 11 231 15 21 84 121
2022/20231.351 98 232 11 122 127 143 0 52 493 3 56 14
2023/2024602 55 32 44 13 7 13 139 9 74 12 107 97
2024/2025170 27 130 13 0 0 0 0 0 0 0 0 0
Totale 4.464